| Literature DB >> 34093185 |
Guangchan Jing1, Huanyuan Wang2, Fengwei Nan3, Yuqin Liu4, Mengren Zhang1.
Abstract
P2X7/NLRP1/caspase-1 mediated neuronal injury plays an important role in diabetic cognitive impairment and eventually inflammatory cascade reaction. Chinese herbal compound Naofucong has been mainly used to treat cognitive disorders in Traditional Chinese Medicine The present study aimed to investigate whether its neuroprotective effects might be related to the inhibition of P2X7R/NLRP1/caspase-1 mediated neuronal injury or not. In this study, high glucose-induced HT22 hippocampal neurons were used to determine Naofucong-containing serum neuronal protective effects. Lentiviruses knock out of TXNIP and P2X7R was used to determine that protective effects of Naofucong was related to inflammatory response and P2X7/NLRP1/caspase-1 mediated neuronal injury. NAC was also used to inhibit oxidative stress, so as to determine that oxidative stress is an important starting factor for neuronal injury of HT22 cells cultured with high glucose. Naofucong decreased apoptosis, IL-1β and IL-18 levels in high glucose-induced HT22 hippocampal neuron cells. Naofucong suppressed NLRP1/caspase-1 mediated neuronal injury, and P2X7 was involved in process. HT22 cells cultured in high glucose had an internal environment with elevated oxidative stress, which could promote neuronal injury. The current study demonstrated that Naofucong could significantly improve high glucose-induced HT22 hippocampal neuron injury, which might be related to suppress P2X7R/NLRP1/caspase-1 pathway, which provides novel evidence to support the future clinical use of Naofucong.Entities:
Keywords: TCM; high glucose; hippocampal neurons; naofucong; pyroptosis
Year: 2021 PMID: 34093185 PMCID: PMC8173084 DOI: 10.3389/fphar.2021.647116
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Related chromatographic mass spectrometric data of compound in naofucong granule.
| No | Rt |
| Proposed fomula | ppm | MSn | Identification |
|---|---|---|---|---|---|---|
| 1 | 5.23 | 197.0455 | C9H9O5 | 1.08 | MS2 [197]179; MS3 [179]135 | Tanshinol |
| 2 | 13.67 | 342.1705 | C20H24NO4 | −1.49 | [342]297,298,265,311; [297]265,282 | Magnoflorine |
| 3 | 14.76 | 417.0830 | C20H17O10 | 1.36 | MS2 [417]373,175,197; MS3 [373]175,197 | Salvianolic acid G |
| 4 | 15.15 | 537.1037 | C27H21O12 | 0.95 | MS2 [537]339,295; MS3 [339]295,321,185 | Lithospermic acid |
| 5 | 15.17 | 557.1301 | C27H25O13 | 1.16 | MS2 [557]313,243,211,405,285 | Piceatannol 4′-galloylglucoside |
| 6 | 15.69 | 717.1466 | C36H29O16 | 1.54 | MS2 [717]519,321; MS3 [519]321,339 | Salvianolic acid L |
| 7 | 16.02 | 359.0774 | C18H15O8 | 1.25 | MS2 [359]161,179(24),197,223(13); MS3 [161]133 | Rosmarinate |
| 8 | 17.24 | 717.1458 | C36H29O16 | 0.8 | MS2 [717]519,321; MS3 [519]321,339 | Salvianolic acid L |
| 9 | 17.28 | 322.1079 | C19H16NO4 | 0.52 | [322]307,308,294 | Thalifendine |
| 10 | 18.04 | 493.1138 | C26H21O10 | 0.91 | MS2 [493]295; MS3 [295]159,185,277,157 | Salvianolic acid A |
| 11 | 18.17 | 493.1138 | C26H21O10 | 0.88 | MS2 [493]295; MS3 [295]159,185,277,157 | Salvianolic acid A |
| 12 | 19.34 | 338.1372 | C20H20NO4 | −1.53 | [338]323,324,294; [323]294,307,308 | Jatrorrhizine |
| 13 | 19.57 | 338.1392 | C20H20NO4 | 0.52 | [338]323,324,294; [323]294,307 | Columbamine |
| 14 | 20.13 | 336.1215 | C20H18NO4 | −1.51 | [336]321,320,308; [321]292,293 | Berberine |
| 15 | 20.93 | 320.0904 | C19H14NO4 | −1.11 | [320]292,290,293; [292]277,264 | Coptisine |
| 16 | 22.59 | 352.1549 | C21H22NO4 | −2.00 | [352]337,336,338; [337]308,320 | Palmatine |
| 17 | 23.19 | 336.1214 | C20H18NO4 | −1.67 | [336]321; [321]292,318 | Epiberberine |
| 18 | 31.19 | 497.3273 | C31H45O6 | 1.12 | MS2 [497]419,435,420,417,269 | Poricoic acid A |
| 19 | 32.75 | 269.0455 | C15H9O5 | 1.08 | MS2 [269]225,269,226,241,201 | Emodin or Aloe-emodin |
| 20 | 35.34 | 469.3324 | C30H45O4 | 1.13 | MS2 [469]423,407,337,333,409 | 3,16-Dihydroxylanosta-7,9 (11),24-trien-21-oic acid |
| 21 | 35.99 | 471.3481 | C30H47O4 | 1.19 | MS2 [471]409,337,410,425,407 | 16 -Hydroxytrametenolic acid |
| 22 | 36.41 | 481.3325 | C31H45O5 | 1.28 | MS2 [481]412,421,403,344,382 | Poricoic acid C |
| 23 | 37.13 | 297.1476 | C19H21O3 | 0.28 | MS2 [297]279,251; MS3 [279]279,264 | Cryptotanshinone |
| 24 | 37.36 | 529.3534 | C32H49O6 | 1.02 | MS2 [529]453,469,511,451,470 | 3-O-acetyl-16,26-dihydroxytrametenolic acid |
| 25 | 37.39 | 483.3482 | C31H47O4 | 1.35 | MS2 [483]437,337,421; MS3 [437]421 | Dehydrotumulosic acid |
| 26 | 40.16 | 481.3325 | C31H45O4 | 1.25 | MS2 [481]311,388,403,335,421 | Poricoic acid C |
| 27 | 41.1 | 529.3536 | C32H49O6 | 1.27 | MS2 [529]483,460,393,392,461 | 3-O-acetyl-16, 27-dihydroxytrametenolic acid |
| 28 | 41.15 | 483.3482 | C31H47O5 | 1.32 | MS2 [483]437,421,423; MS3 [437]421 | Dehydrotumulosic acid |
| 29 | 46.82 | 527.3742 | C33H51O5 | 1.11 | MS2 [527]509,481,511,483 | Pachymic acid |
Naofucong reduced high glucose-induced HT22 hippocampal neuron cell damage.
FIGURE 1Naofucong reduced high glucose-induced HT22 hippocampal neuron cell damage. (A) The activity of HT22 cells cultured with high glucose at different concentrations and at different time points, *** p < 0.001, 75 mmol/L vs. Con. (B, C) HT22 cell activity and LDH release level under high glucose conditions (75 mmol/L and 48 h), NFC or lentivirus knockout of TXNIP treatment. Values are means ± SEM, n = 5 per group, * p < 0.05, ** p < 0.01, *** p < 0.001.
FIGURE 2Naofucong decreased apoptosis, IL-1β and IL-18 levels in high glucose-induced HT22 hippocampal neuron cells. (A) Morphological photomicrographs of TUNEL staining. TUNEL positive staining cells were labeled as green, scale bar = 30 μm. (B, C) Effects of NFC on IL-1β and IL-18 levels of HT22 cells in high glucose. (D, E) Effects of NFC on IL-1β and IL-18 mRNA levels of HT22 cells in high glucose. Values are means ± SEM, n = 5 per group, * p < 0.05, ** p < 0.01, *** p < 0.001. Naofucong suppressed NLRP1/caspase-1 mediated neuronal injury in high glucose-induced HT22 hippocampal neuron cells.
FIGURE 3Naofucong suppressed NLRP1/caspase-1 mediated neuronal injury in high glucose-induced HT22 hippocampal neuron cells. (A) Effects of NFC on NLRP1, ASC, pro-caspase-1, caspase-1, and GSDMD levels of HT22 cells in high glucose. (B–E) Representative protein levels of NLRP1, ASC, pro-caspase-1, caspase-1, and GSDMD levels of HT22 cells in high glucose were assessed by western blotting using specific antibodies. Values are means ± SEM, n = 4 per group, * p < 0.05, ** p < 0.01, *** p < 0.001. Naofucong suppressed P2X7-induced neuronal injury in high glucose-induced HT22 hippocampal neuron cells.
FIGURE 4Naofucong suppressed P2X7-induced neuronal injury in high glucose-induced HT22 hippocampal neuron cells. (A) Effects of NFC on P2X7R, NLRP1, ASC, pro-caspase-1, caspase-1, and GSDMD levels of HT22 cells in high glucose. (B–F) Representative protein levels of P2X7R, NLRP1, ASC, pro-caspase-1, caspase-1, and GSDMD levels of HT22 cells in high glucose were assessed by western blotting using specific antibodies. (G, H) Effects of NFC and P2X7R-miRNA on NLRP1 and ASC mRNA levels of HT22 cells in high glucose. Values are means ± SEM, n = 4 per group, * p < 0.05, ** p < 0.01, *** p < 0.001.
FIGURE 5Oxidative stress was involved in process of NFC suppressing P2X7/NLRP1/caspase-1 mediated neuronal injury in high glucose-induced HT22 cells. (A) Effects of NAC on P2X7R, NLRP1, ASC, pro-caspase-1, caspase-1, and GSDMD levels of HT22 cells in high glucose. (B–F) Representative protein levels of P2X7R, NLRP1, ASC, pro-caspase-1, caspase-1, and GSDMD levels of HT22 cells in high glucose were assessed by western blotting using specific antibodies. (G, H) Effects of NFC and NAC on NLRP1, and ASC mRNA levels of HT22 cells in high glucose. Values are means ± SEM, n = 4 per group, * p < 0.05, ** p < 0.01, *** p < 0.001.